FI  Thiel Capital

http://thielcapital.com/





     Office Locations:

One Letterman Drive, Building C, Suite 400
San Francisco, CA 94129

 

Stages:

  • Early


 

Industries:

  • Information Technology
  • Software & Internet

  •  

    Description:

    Thiel Capital is an investment firm founded by Peter Thiel. Located in the Presidio of San Francisco, Thiel Capital provides strategic and operational support for Peter Thiel's many investment initiatives and entrepreneurial endeavors. Related organizations include Clarium, Founders Fund, Mithril, Valar Ventures, and The Thiel Foundation.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or Silicon Valley Database subscription.
    Blake Masters COO
    Eric Weinstein Managing Director
    Peter Thiel Founder

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      08/08/2018


      SPARK Neuro


      NY


      $13,500,000


      Series A


      07/12/2018


      Compass Therapeutics


      MA


      $132,000,000


      Series A


     

    Portfolio companies include:

     

    Recent News: